Publications by authors named "A Kubatiev"

We propose a model of combination treatment of Lewis lung carcinoma (LLC) in C57BL/6 mice that includes tumor resection and chemotherapy. A single injection of 5×106 LLC cells into the right lateral subcostal region caused the growth of the primary tumor and its metastasis to the lung. For reducing metastasis and mortality after resection, the primary tumor should be removed with subcutaneous fat on day 8 after inoculation.

View Article and Find Full Text PDF

A new approach of total major aminothiols determination (cysteine, homocystine, cysteinylglycine, and glutathione) in human plasma by capillary electrophoresis (CE) is presented. It is based on the analytes reduction by tris (2-carboxyethyl) phosphine and derivatization with N-ethylmaleimide, with subsequent ultrafiltration of the sample. Separation was performed using 0.

View Article and Find Full Text PDF

We studied the effect of reprogrammed CD8 T cells (rT cells) from the bone marrow of intact mice on tumor cells and neovasculogenesis in mice with orthotopic Lewis lung carcinoma (LLC). Reprogramming of T cells was carried out using a MEK inhibitor and a PD-1 blocker; the targeting of rT cells to tumor cells was achieved by preincubation with LLC cell lysate. It was shown that the antitumor effect of rT cells was based on apoptosis of tumor cells.

View Article and Find Full Text PDF

Background: Awareness of age-related features of carcinogenesis and the importance of cellular immunity is crucial for developing effective antitumor therapies for specific patient groups.

Methods: In this study, we examined different populations of cancer stem cells (CSCs) and circulating tumor cells (CTCs) in "young" (8-10 weeks) and "aged" (80-82 weeks) C57BL/6 male mice. We used an orthotopic model of Lewis lung carcinoma (LLC) to evaluate the effectiveness of cell therapy targeting lung cancer through reprogrammed CD8-positive T cells (rCD8+ T cells) in mice from two different ages.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the effects of the dopamine D2 receptor antagonist spiperone on combined lung conditions—emphysema and lung cancer—in C57BL/6 mice.
  • Results indicated that spiperone reduced lung inflammation, tumor size, and metastasis, along with decreasing the number of cancer stem cells (CSCs) in both the lungs and blood of treated mice.
  • The findings suggest that targeting dopamine D2 receptors could be a viable strategy for treating lung cancer in patients suffering from emphysema.
View Article and Find Full Text PDF